Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Placebo Controlled, Dose Escalation Study in Subjects With Type 2 Diabetes Mellitus Being Treated With Sulfonylurea

This study has been completed.
Information provided by:
Isis Pharmaceuticals Identifier:
First received: April 2, 2007
Last updated: August 26, 2009
Last verified: August 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2009
  Primary Completion Date: March 2009 (Final data collection date for primary outcome measure)